Expiring federal contract · order under a contract vehicle
36C24426N0199 — Beckman Coulter, INC
Department of Veterans Affairs
- Contract / PIID
- 36C24426N0199
- Incumbent
- Beckman Coulter, INC
- Incumbent UEI
- PU6HHX2R11C7
- Current end date
- November 30, 2026
- Potential total value
- $128,820
- Obligated
- $128,820
- NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- PSC
- Q301 — REFERENCE LABORATORY TESTING
- Set-aside
- Full & Open
- Start date
- December 1, 2025
- Place of performance
- PA
- Award type
- BPA CALL
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
VISN 04 MICROBIOLOGY TESTING PHILADELPHIA TASK ORDER
Likely rebid window (estimate)
- Sources Sought / RFI: about Nov 2025 – May 2026 (6–12 months before the end date)
- RFP: about Jul 2026 – Sep 2026 (2–4 months before the end date)
In the final months before the current end date.
This is an order under contract vehicle 36C24426A0008. Orders are usually not competed on their own: the next order may be placed under the same vehicle.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Veterans Affairs (NAICS 325413)
- 36C24126F0009 — Fisher Scientific Company L.L.C. · ends November 23, 2026 · $349K
- 36C24426N0200 — Beckman Coulter, INC · ends November 30, 2026 · $115K
- 36C24426N0201 — Beckman Coulter, INC · ends November 30, 2026 · $104K
- 36C24426N0202 — Beckman Coulter, INC · ends November 30, 2026 · $110K
- 36C24526P0090 — Cepheid · ends November 30, 2026 · $215K
- 36C25026N0722 — Sebia, INC. · ends November 30, 2026 · $103K
- 36C25726N0059 — Qiagen, LLC · ends November 30, 2026 · $107K
- 36C25926N0155 — Abbott Molecular INC. · ends November 30, 2026 · $350K
- 36C26024P0112 — Biofire Diagnostics LLC · ends November 30, 2026 · $644K
- 36C24626N0099 — Biomerieux INC · ends December 2, 2026 · $162K